L.TO (Loblaw Companies Limited) TSX C$68.58 Feb 20, 2026: Earnings week could shift outlook
L.TO stock trades at C$68.58 intraday on the TSX on Feb 20, 2026, with 944,545 shares changing hands today as investors position ahead of Loblaw’s earnings due Feb 25, 2026. This earnings spotlight looks at near-term revenue drivers, margins, and what management’s AI and digital commerce updates mean for the March quarter. We highlight valuation levels, analyst targets and Meyka AI’s model that frames upside and downside into the earnings print.
Earnings calendar and immediate catalyst for L.TO stock
Loblaw Companies Limited (L.TO) reports results on Feb 25, 2026; that print is the primary near-term catalyst for L.TO stock. Investors should watch same-store sales, pharmacy margins and commentary on AI-driven digital commerce after Loblaw’s Feb 19 Google collaboration announcement (source).
Advertisement
Recent news, strategy and what it means for L.TO stock
Loblaw said on Feb 19 it will expand AI-led shopping with Google and scale Google Cloud Vertex AI. That initiative could lift online conversion and reduce inventory friction, a positive for gross margin and inventory turnover. The partnership is already priced into short-term sentiment but it is a real operational catalyst if Loblaw converts AI investments into measurable margin gains.
Valuation and financial snapshot for L.TO stock
At C$68.58, Loblaw shows a trailing EPS of 2.05 and a reported P/E of 33.46 on the intraday quote. Market cap is C$81,028,455,178.00, 50-day average price C$62.77 and 200-day C$58.12. Key ratios to watch into earnings: free cash flow per share C$12.27, return on equity 22.31%, and debt-to-equity ~1.75, which highlights leverage risk versus peers.
Technical and trading setup around earnings for L.TO stock
Technicals show momentum: RSI 71.60 (overbought) and ADX 30.55 signaling a strong trend, with day range C$68.15–C$68.78. Average volume is 1,398,672 but intraday volume is 944,545, suggesting lighter participation than the 50‑day average. Traders should watch the post-earnings gap and support near the 50‑day average at C$62.77.
Meyka AI grade and forecast for L.TO stock
Meyka AI rates L.TO with a score out of 100: 79.37 (B+) — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly C$74.74 and yearly C$153.79. That implies an intraday-to-month upside of 8.99% and a 12‑month upside of 124.30% from C$68.58. Forecasts are model-based projections and not guarantees. For more on the research and price context see our L.TO stock page: Meyka L.TO profile.
Analyst views, price targets and risk factors for L.TO stock
Analysts are mixed but skew positive: consensus price target reported at C$89.75 (MarketBeat) implying 30.89% upside from current levels (source). Recent targets include RBC C$72.00, CIBC C$67.00 and Desjardins C$67.00. Key risks ahead of earnings: margin compression at pharmacy, higher freight and labour costs, and leverage if free cash flow falls short.
Final Thoughts
L.TO stock is in focus this intraday session at C$68.58 as markets price in Loblaw’s Feb 25, 2026 earnings. The stock carries mixed signals: strong earnings growth and ROE contrast with elevated leverage and an overbought technical reading. Analysts place a consensus target near C$89.75 (implied upside 30.89%). Meyka AI’s model projects C$74.74 in the next month (implied 8.99% upside) and C$153.79 at 12 months (implied 124.30% upside). Use the earnings print to track company guidance on margins and AI-driven digital sales, and watch liquidity: average daily volume 1,398,672 versus today’s 944,545. These figures and targets frame a risk/reward profile where earnings execution will determine whether L.TO stock extends gains or trades back toward its 50‑day mean around C$62.77. Forecasts are model-based projections and not guarantees.
Advertisement
FAQs
When does Loblaw report earnings and why does that matter for L.TO stock?
Loblaw reports on Feb 25, 2026. The print matters because management’s guidance on same-store sales, pharmacy margins and digital commerce adoption will drive short-term share moves in L.TO stock.
What are the nearest analyst price targets for L.TO stock?
Analysts show a spread. MarketBeat consensus is C$89.75, RBC at C$72.00, and CIBC at C$67.00. That range reflects differing views on margin recovery and digital revenue growth for L.TO stock.
What is Meyka AI’s short and 12‑month forecast for L.TO stock?
Meyka AI’s forecast model projects C$74.74 monthly and C$153.79 yearly from the current C$68.58. Forecasts are model-based projections and not guarantees.
What are the main risks to watch in the upcoming Loblaw earnings for L.TO stock?
Key risks include weaker pharmacy margins, higher supply chain costs, and disappointing digital commerce monetization. Leverage metrics and free cash flow will be central for L.TO stock reaction.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)